C4 THERAPEUTICS INC shareholders Q3 2023

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.

C4 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,990,334$3,702,0213.36%
Lynx1 Capital Management LP 1,019,230$1,895,7681.25%
Soleus Capital Management, L.P. 2,692,020$5,007,1570.46%
TCG Crossover Management, LLC 1,276,574$2,374,4270.35%
Bain Capital Life Sciences Investors, LLC 1,642,210$3,054,5110.34%
Nextech Invest Ltd. 375,857$699,0940.21%
Nantahala Capital Management 1,000,000$1,860,0000.16%
WASATCH ADVISORS LP 6,247,141$11,619,6820.07%
ArrowMark Colorado Holdings LLC 2,376,806$4,420,8590.05%
XTX Topco Ltd 96,042$178,6380.03%
HARBOR CAPITAL ADVISORS, INC. 70,703$131,5080.03%
CORNERCAP INVESTMENT COUNSEL INC 47,456$88,2680.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 864,481$1,607,9350.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 149,000$277,1400.01%
PRELUDE CAPITAL MANAGEMENT, LLC 51,149$95,1370.01%
ALGERT GLOBAL LLC 51,760$960.01%
AQR Capital Management 1,093,099$2,033,1640.00%
Pale Fire Capital SE 19,200$35,7120.00%
TWO SIGMA ADVISERS, LP 706,100$1,313,3460.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 17,572$32,6840.00%
External links

This page lists C4 THERAPEUTICS INC's shareholders in Q3 2023. To view C4 THERAPEUTICS INC's shareholder history, click here.